Price Alert

Lisata Therapeutics Inc. (LSTA)

NASDAQ: LSTA · Real-Time Price · USD

2.52

-0.04 (-1.56%)

At close: Aug 15, 2025, 3:59 PM

2.53

0.40%

After-hours: Aug 15, 2025, 04:00 PM EDT

Lisata Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	16.84M	20.22M	16.21M	19.51M	28.29M	21.8M	22.59M	32.43M	23.69M	28.16M	32.15M	31.48M	33.35M	12.75M	24.65M	12.77M	12.94M	28.74M
Short-Term Investments	5.13M	5.62M	15.04M	16.35M	9.97M	21.54M	27.94M	21.97M	33.94M	32.94M	37.07M	44.05M	39.64M	75.77M	70.32M	87.38M	93.16M	82.77M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	10M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	70K	116K	160K	201K	21K	23K	24K	371K	23K	449K	528K	588K	648K	708K	764K	361K	42K	41K
Receivables	501K	750K	900K	200K	1M	1M	1M	500.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-500	-1.1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.41M	2.03M	2.43M	1.64M	2.72M	-1M	n/a	2.84M	3.8M	4.2M	2.65M	1.76M	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	24.89M	28.62M	34.58M	37.69M	41.98M	47.56M	53.92M	57.23M	61.42M	65.3M	71.88M	77.29M	74.95M	90.7M	96.18M	102.11M	108.08M	114.03M
Property-Plant & Equipment	48K	74K	72K	96K	344K	413K	483K	204K	620K	262K	296K	299K	282K	55K	62K	70K	492K	533K
Goodwill & Intangibles	157K	174K	192K	210K	228K	245K	263K	281K	299K	317K	334K	352K	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	275K	364K	424K	507K	593K	681K	770K	856K	942K	1.03M	1.16M	1.24M	10.93M	763K	826K	431K	534K	574K
Total Assets	25.16M	28.98M	35M	38.2M	42.57M	48.24M	54.69M	58.09M	62.37M	66.33M	73.03M	78.53M	85.88M	91.46M	97.01M	102.54M	108.61M	114.61M
Account Payables	782K	602K	1.28M	556K	728K	1.26M	2.42M	1.31M	775K	1.34M	2.65M	974K	1.1M	697K	1.93M	768K	1.24M	2.31M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-164K	-160K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	47K	92K	137K	181K	176K	172K	168K	164K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.35M	-92K	-137K	-181K	-176K	2.31M	1.11M	n/a	1.09M	1.66M	962K	3.07M	685K	894K	n/a	1.2M	859K	623K
Total Current Liabilities	4.31M	3.81M	5.61M	4.69M	4.46M	5.33M	6.59M	5.13M	4.36M	5.29M	6.38M	6.39M	3.36M	2.8M	4.52M	4.07M	3.86M	4.44M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	72K	72K	72K	72K	72K	72K	73K	72K	72K	72K	22K	22K	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	72K	72K	72K	72K	119K	164K	210K	253K	295K	337K	327K	367K	383K	421K	485K	53K	79K	155K
Total Liabilities	4.38M	3.88M	5.68M	4.76M	4.58M	5.5M	6.8M	5.38M	4.65M	5.62M	6.71M	6.76M	3.74M	3.22M	5.01M	4.13M	3.94M	4.59M
Total Debt	47K	92K	137K	181K	223K	264K	305K	164K	383K	421K	485K	548K	561K	626K	714K	350K	445K	536K
Common Stock	9K	9K	8K	8K	8K	8K	8K	8K	8K	8K	8K	8K	61K	61K	60K	60K	60K	60K
Retained Earnings	-557.45M	-552.79M	-548.07M	-543.46M	-538.53M	-533.48M	-528.08M	-522.72M	-517.46M	-513.43M	-507.24M	-501.25M	-463.87M	-457.24M	-453.02M	-446.22M	-439.3M	-433.61M
Comprehensive Income	-50K	-78K	-81K	-32K	-77K	-104K	-42K	-100K	-50K	-52K	-29K	-90K	-70K	-196K	-70K	-64K	-17K	-72K
Shareholders Equity	21.03M	25.36M	29.57M	33.69M	38.25M	43M	48.15M	52.96M	57.97M	60.96M	66.58M	72.03M	82.39M	88.5M	92.25M	98.67M	104.93M	110.27M
Total Investments	5.13M	5.62M	15.04M	16.35M	9.97M	21.54M	27.94M	21.97M	33.94M	32.94M	37.07M	44.05M	49.64M	75.77M	70.32M	87.38M	93.16M	82.77M